The development of the combinatorial chemistry of phosphinic peptides has led to the discovery of both highly potent and selective inhibitors of various zinc metalloproteinases. Several properties of these compounds are reviewed, supporting the view that this class of inhibitors should represent useful tools for probing several aspects of the function of this broad family of proteases in w ivo .
Introduction
The discovery of highly potent, but also highly selective, inhibitors of proteases able to discriminate between the different members of this very large family of proteins [l] still represents a formidable challenge. Post-genomic programs will Key words: combinatorial chemistry, inhibitor, phosphinic peptide, Zn-metallopmteinase. Abbreviations used: 24-15, thimet oligopeptidase (EC 3.4.24 . IS); neurolysin (EC 3.4.24.16) . 'To whom correspondence should be addressed (e-mail dive@dsvidQ.ceafr).
identify many more new proteases belonging to this family, thus making the development of selective inhibitors a much more difficult task. Combinatorial chemistry, among others, constitutes an attractive attempt to approach protease diversity. These considerations led us several years ago to develop focused libraries containing compounds able to target zinc proteinases. Peptides containing a phosphinic moiety were chosen, assuming that they would mimic reasonably well the structure of the transition state of the substrates cleaved by these enzymes (Scheme 1). In addition, the good chemical stability of the P-C bond of the phosphinic moiety should overcome the problem frequently observed with phosphonamide peptides : hydrolysis of the P-N bond [2-4].
Analogy with the transition state
As far as the stabilization of the substrate in the transition state is concerned, it has been assumed that the scissile peptide bond moiety, all along the hydrolytic pathway, should engage in several tight interactions with groups of atoms present in the The high inhibitory potency displayed by phosphinic peptides is still an intriguing issue, but the resolution of the three-dimensional structure of the first complex between a zinc proteinase and a phosphinic peptide inhibitor has shed interesting light on this subject. In fact, in this structure one hydrogen atom of the phosphinic methylene group is within hydrogen-bonding distance of a protein carbonyl group, whereas the phosphoryl group interacts with the Zn2+ ion, as expected (Figure 1) 
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The same kind of interactions have recently been observed in a complex between a phosphinic peptide inhibitor and stromelysin 3, a matrixin zinc metalloproteinase (A. L. Gall, unpublished work), confirming the particular ability of the phosphinic CH, group to form a hydrogen bond with a protein carbonyl group. Taken together, these observations support the view that phosphinic peptides are good mimics of the transition state, a property consistent with their potent ability to block zinc metalloproteinases.
Combinatorial chemistry approach
The combinatorial chemistry approach that we selected relies on phosphinic peptide synthesis by a simple solid-phase procedure [17]. In this approach, phosphinic dipeptide blocks were produced in a form resembling those of a standard amino acid, ready for use in Fmoc (fluoren-9-ylmethoxycarbonyl) solid-phase peptide synthesis, the most popular strategy in synthesizing natural peptides. Thus instead of a single amino acid we produced a pseudo-dipeptide phosphinic synthon, in which the N-terminal and hydrophosphoryl polar functions were protected by Fmoc and adamantyl groups respectively (Figure  2) .
At this stage, the stereochemistry at the R, and R, positions was not addressed and thus the phosphinic blocks were used as a mixture of four enantiomers. Clearly, the major drawback of this approach is that the chemical structures of the P1 and P1' positions (corresponding to R, and R,) are fixed, thus allowing diversity to be introduced only in the positions framing the phosphinic block. 
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However, despite this limitation, even with a single phosphinic block, we speculated that potentially useful phosphinic peptide mixtures could be obtained [12,13]. Given a tetrapeptide, three types of library could be prepared, depending on the position of the phosphinic moiety in the peptide sequence, each containing 400 different phosphinic peptides (Figure 3) . If the presence of R and S configurations at the P1 and P1' positions are taken into account, each library contains 1200
structures. The first step of the screening involves the selection of the best mixture in terms of potency and selectivity toward the target of interest. In this way, the best position of the phosphinic block in the tetrapeptide sequence can be identified independently of the amino acid composition on each side of the phosphinic block. Using a PheY(P0,-CH,)Ala block (in which Y indicates that the peptide bond has been modified, and the formula of the group that has replaced this peptide bond is in parentheses), we discovered phosphinic peptides able to inhibit the Another important structural feature in the selectivity of this inhibitor was the presence of an aspartic residue in the inhibitor P2 position.
In this case the selectivity for the N-domain arose mostly because the presence of the aspartic residue and a C-terminal carboxamide group were not tolerated by the C-domain, whereas these features were accommodated by the N-domain.
The 24-16 inhibitor and RXP407 are examples of compounds in which the P2 position has an important role in the potency and selectivity of the inhibitor. In this respect, in comparison with thiol, hydroxamate or carboxyl-alkyl peptide inhibitors, only phosphinic peptide chemistry offers the possibility of developing inhibitors able to exploit both sides of the enzyme's active site.
Evolution of phosphinic peptide chemistry
The synthesis of large collections of phosphinic blocks is hampered by the difficulty of producing aminophosphinic acids and acrylates, the necessary building blocks for synthesizing phosphinic peptides. More recently we encountered another unexpected limitation of this approach by observing the first example of an unsuccessful Michael addition. T o develop a potent inhibitor of zinc glutamyl aminopeptidase, synthesis of phosphinic peptides containing in their P1 position an aspartyl or glutamyl aminophosphinic acid was envisaged ( Figure 5 ). Despite many attempts, the Taking into account the importance of the S1'
subsite in the selectivity of many proteases, an efficient chemical method permitting the introduction of a great chemical diversity in the P1' position of a common phosphinic precursor would be extremely useful. Such a strategy would be particularly attractive for developing inhibitors able to discriminate between the different members of the matrix metalloproteinases, which are characterized by an atypical tunnel-like S1' subsite and are able to accommodate very different unusual chemical groups [15, 21] . RXP03 ( Figure  4) is an example of a phosphinic peptide inhibitor of matrixins bearing in its P1' position such an unusual side chain [21] .
Metabolism of phosphinic peptides in vivo
Although phosphinic peptides cannot be considered as leads for direct therapeutic applications, in particular because of limited oral absorption, they could prove useful in probing the function of zinc metalloproteinases. Obviously, for this kind of application the metabolism of such compounds in eriero is of considerable importance. Owing to the presence of peptide bonds in their structure, the degradation of phosphinic peptides by nonspecific proteases from the plasma and their metabolism in the liver have always been considered as major limitations to their use in vivo.
To address this issue, two phosphinic peptides, RXP407 (an inhibitor of angiotensin-converting enzyme) and RXP03 (a matrixin inhibitor), were radiolabelled to study their metabolism in vivo (Figure 4) . RXP407, injected intraperitoneally into either rats or mice, was completely recovered intact in urine, despite the presence of four peptide bonds in its structure [18]. RXPO3 injected into mice was also completely unmetabolized, being eliminated intact in the bile. Obviously, even restricted to two phosphinic peptides, these observations are extremely interesting and support the contention that this class of compounds might be of broader use in studying the function of zinc metalloproteinases in vivo. One possible explanation for the unexpected absence of metabolism could be the presence of a strong negative charge on the phosphoryl group, preventing the uptake of these compounds by the liver cells and their interaction with non-specific proteinases of the plasma [22] .
Conclusion
The development of phosphinic compounds is still in its infancy. Many chemical possibilities are still unexplored. Owing to their ability to target zinc peptidases, focused libraries of phosphinic peptides can be developed that contain only a rather limited number of molecules, making the screening and deconvolution of these libraries a simple task, with a high success rate in identifying potent and highly selective inhibitors of zinc peptidases. Finally, if our preliminary obser-vations on the absence of metabolism of these phosphinic peptides in vivo can be generalized, compounds to the probing of many aspects of the function of this family of proteases in vivo.
